These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23796514)

  • 21. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
    Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
    PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
    Savelyeva I; Dobbelstein M
    Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A6 - new facts and features.
    Leśniak W; Słomnicki ŁP; Filipek A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1087-92. PubMed ID: 19891957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.
    Sinha S; Malonia SK; Mittal SP; Mathai J; Pal JK; Chattopadhyay S
    Int J Biochem Cell Biol; 2012 Jan; 44(1):46-52. PubMed ID: 22074660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and localization of S100A6 in human umbilical cord.
    Jurewicz E; Kasacka I; Bańkowski E; Filipek A
    Cell Biol Int; 2012 Jan; 36(1):109-12. PubMed ID: 21923636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
    Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
    J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.
    Cho H; Ahn DR; Park H; Yang EG
    FEBS Lett; 2007 Apr; 581(8):1542-8. PubMed ID: 17382325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.
    Shiseki M; Nagashima M; Pedeux RM; Kitahama-Shiseki M; Miura K; Okamura S; Onogi H; Higashimoto Y; Appella E; Yokota J; Harris CC
    Cancer Res; 2003 May; 63(10):2373-8. PubMed ID: 12750254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsp70 is a new target of Sgt1--an interaction modulated by S100A6.
    Spiechowicz M; Zylicz A; Bieganowski P; Kuznicki J; Filipek A
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1148-53. PubMed ID: 17466273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding and functional characteristics of two E-box motifs within the S100A6 (calcyclin) gene promoter.
    Leśniak W; Kuźnicki J
    J Cell Biochem; 2006 Apr; 97(5):1017-24. PubMed ID: 16288473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Members of the S100 family bind p53 in two distinct ways.
    Fernandez-Fernandez MR; Rutherford TJ; Fersht AR
    Protein Sci; 2008 Oct; 17(10):1663-70. PubMed ID: 18694925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative regulation of the p300-p53 interplay by DDX24.
    Shi D; Dai C; Qin J; Gu W
    Oncogene; 2016 Jan; 35(4):528-36. PubMed ID: 25867071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence.
    Miyajima C; Kawarada Y; Inoue Y; Suzuki C; Mitamura K; Morishita D; Ohoka N; Imamura T; Hayashi H
    Cells; 2020 Jan; 9(1):. PubMed ID: 31936650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Life and death of transcriptional co-activator p300.
    Chen J; Li Q
    Epigenetics; 2011 Aug; 6(8):957-61. PubMed ID: 21730760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognition.
    Lee YT; Dimitrova YN; Schneider G; Ridenour WB; Bhattacharya S; Soss SE; Caprioli RM; Filipek A; Chazin WJ
    Biochemistry; 2008 Oct; 47(41):10921-32. PubMed ID: 18803400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.
    van Dieck J; Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
    J Biol Chem; 2009 May; 284(20):13804-13811. PubMed ID: 19297317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy.
    Sebti S; Prébois C; Pérez-Gracia E; Bauvy C; Desmots F; Pirot N; Gongora C; Bach AS; Hubberstey AV; Palissot V; Berchem G; Codogno P; Linares LK; Liaudet-Coopman E; Pattingre S
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4115-20. PubMed ID: 24591579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.